Reports from Louisiana State University Health Sciences Center Advance Knowledge in Otitis (Non-protective immunity after standard pneumococcal vaccination series identified as a potential contributing risk factor for refractory otolaryngologic...).

Předmět:	PNEUMOCOCCAL vaccines OTITIS MEDICAL centers POLYPOIDAL choroidal vasculopathy IMMUNITY STATE universities & colleges
Zdroj:	Vaccine Weekly; 7/21/2023, p231-231, 1p
Abstrakt:	Keywords: Antibodies; Biological Products; Blood Proteins; Communicable Disease Control; Diagnostics and Screening; Ear Diseases and Conditions; Environment and Public Health; Health and Medicine; Immunization; Immunoglobulins; Immunology; Otitis; Otolaryngology; Otorhinolaryngologic Diseases and Conditions; Pediatrics; Proteins; Public Health; Public Health Practice; Risk and Prevention; Vaccination; Vaccines EN Antibodies Biological Products Blood Proteins Communicable Disease Control Diagnostics and Screening Ear Diseases and Conditions Environment and Public Health Health and Medicine Immunization Immunoglobulins Immunology Otitis Otolaryngology Otorhinolaryngologic Diseases and Conditions Pediatrics Proteins Public Health Public Health Practice Risk and Prevention Vaccination Vaccines 231 231 1 07/17/23 20230721 NES 230721 2023 JUL 19 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators discuss new findings in otitis. Pneumococcal antibody titer results were assessed for children ages 0 to 21 years and: (1) at least 1 of 7 otolaryngologic disease diagnoses and (2) having received the 4-dose schedule of pneumococcal conjugate vaccine (PCV 7 or 13). [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu